Bullish Moving Averages
2
Bearish Moving Averages
14
Back Stocks profile
Open Price
88.50Prev. Close
76.1000Volume
38928.00Value
3337297.44Market Cap Cr
225.00
Price to Earnings
-11.50
Price to Book Value
3.40
Dividend Yield
0.00
PE to Growth
-0.40
Op Revenue TTM Cr
79.49
Net Profit TTM Cr
-19.59
Cash From Operating Activity Cr
-9.68
Return on Equity %
-29.87
EMA & SMA
Bullish Moving Averages
2
Bearish Moving Averages
14
DELIVERY AND VOLUME
02 Jul, 2024
Week
Month
LEGEND
Positive Indicator
Neutral Indicator
Negative Indicator
RESISTANCE AND SUPPORT
PIVOT
First Resistance
87.22
Second Resistance
88.82
Third Resistance
90.18
First Support
84.26
Second Support
82.90
Third Support
81.30
Relative Strength Index
47.36
Money Flow Index
61.8
MACD
-0.56
MACD Signal
-1.2
Average True Range
3.95
Average Directional Index
14
Rate of Change (21)
6.37
Rate of Change (125)
-40.37
Commodity Channel Index
32.7
Williams %R
-53.5
BETA
1 Month
0.38
3 Month
0.51
1 Year
0.81
3 Year
0.5
PRICE CHANGE ANALYSIS
1 Week
Low
High
84
90.85
1 Month
Low
High
73.25
92
3 Months
Low
High
73.25
116
6 Months
Low
High
73.25
185.7
1 Year
Low
High
73.25
185.7
BROOKS LABORATORIES LTD. - 533543 - Closure of Trading Window
Intimation for Closure of Trading Window.BROOKS LABORATORIES LTD. - 533543 - Compliances-Reg.24(A)-Annual Secretarial Compliance
Annual Secretarial Compliance Report for the Financial Year ended 31st March, 2024BROOKS LABORATORIES LTD. - 533543 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Newspaper PublicationBROOKS LABORATORIES LTD. - 533543 - Financial Results For Quarter And Financial Year Ended March 31, 2024
Financial Results for Quarter and Financial Year ended March 31,2024BROOKS LABORATORIES LTD. - 533543 - Board Meeting Outcome for Board Meeting Outcome For Submission Of Audited Standalone And Consolidated Financial Results For Quarter And Financial Year Ended March 31, 2024.
Board Meeting Outcome For Submission of Audited Standalone And Consolidated Financial Results For Quarter And Financial Year Ended March 31, 2024.BROOKS LABORATORIES LTD. - 533543 - Board Meeting Intimation for Approval Of Audited Financial Results For March 31, 2024
BROOKS LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 18/05/2024 ,inter alia, to consider and approve Audited Standalone and Consolidated Financial Results of the company for the quarter and year ended 31st March 2024.BROOKS LABORATORIES LTD. - 533543 - Certificate Under Regulation 40(9) Of SEBI (Listing Obligations And Disclosure Requirements), Regulations, 2015 For Financial Year Ended 31.03.2024
Certificate under Regulation 40(9) of SEBI (LODR) Regulation 2015 for Financial year ended 31.03.2024BROOKS LABORATORIES LTD. - 533543 - Certificate Under Regulation 40(9) Of SEBI (Listing Obligations And Disclosure Requirements), Regulations, 2015 For Financial Year Ended 31.03.2024.
Certificate under Regulation 40(9) of SEBI (LODR) Regulation 2015 for financial year ended 31.03.2024.BROOKS LABORATORIES LTD. - 533543 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Compliance Certificate under Regulation 74(5) of SEBI (DP) Regulation 2018 for quarter ended March 31,2024BROOKS LABORATORIES LTD. - 533543 - Shareholder Meeting / Postal Ballot-Outcome of AGM
Revised Proceedings and Outcome of 21st AGM held on 21st September, 2023.The latest market price of Brooks Laboratories Ltd. on NSE was Rs. 85.73 as of today.
The opening share price of Brooks Laboratories Ltd. was Rs. 88.50 as of today.
The 52-week high share price of Brooks Laboratories Ltd. was Rs. 185.70.
The 52 week low share price of Brooks Laboratories Ltd. was Rs. 73.20.
Brooks Laboratories Ltd. has a market cap of Rs. 225.00 crore as of today. Please refer to the Fundamentals section for further details.
The PE ratio of Brooks Laboratories Ltd. is -0.40. Please refer to the Fundamentals section for further details.
The operating revenue for Brooks Laboratories Ltd. in the last FY was Rs. 79.49 crore. Please refer to the Financials section for further details.
The Net Profit for Brooks Laboratories Ltd. in the last FY was Rs. -19.59 crore. Please refer to the Financials section for further details.
Please refer to Stock Ants, Bigul’s Community Access platform that aggregates tips and research from experts and provides real-time tracking to help investors validate, discover new investment ideas, and make informed decisions. Click here to learn more.
Please refer to Stock Ants, Bigul’s Community Access platform that aggregates tips and research from experts and provides real-time tracking to help investors validate, discover new investment ideas, and make informed decisions. Click here to learn more.
Please refer to Bigul Traders Corner, One Stop destination for different algo and non-algo trading strategies and tools meant for investors, traders, and strategists. Our qualified experts with rich experience in broking, financial analysis, and software development designed it in-house. Click here to learn more.
Please refer to JARVIS, which is Bigul’s AI Portfolio Manager Tool that uses artificial intelligence algorithms to make investment decisions in a portfolio. Click here to learn more.
Please refer to the News section for the latest news about Brooks Laboratories Ltd..